prednisone has been researched along with Hepatitis C in 81 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We assessed whether conversion from tacrolimus (TAC) to cyclosporine (CsA) was associated with a reduction in hepatitis C virus (HCV) viral load among HCV-positive liver transplant (OLT) patients." | 7.74 | Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study. ( Durand, D; Esposito, L; Faguer, S; Guitard, J; Kamar, N; Lavayssière, L; Lavit, M; Muscari, F; Péron, JM; Ribes, D; Rostaing, L; Sandres-Sauné, K, 2007) |
| " In this study, this model was applied to investigate the effects of prednisone on alanine aminotransferase (ALT) and hepatitis C virus (HCV) RNA levels in chronic hepatitis C." | 7.69 | Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. ( Adkins, RH; Charboneau, F; Fong, TL; Govindarajan, S; Redeker, AG; Valinluck, B, 1994) |
| "Patients with chronic hepatitis C and autoantibodies show a favorable response to interferon, but not to prednisone." | 7.69 | Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. ( Abreu, L; Albillos, A; Cacho, G; Calleja, JL; Escartín, P; Iborra, J, 1996) |
| " Liver transplant recipients with a pre-transplant history of cirrhosis due to alcohol, hepatitis C, and prednisone exposure deserve more caution during PTDM screening." | 4.12 | Risk factors associated with diabetes after liver transplant. ( Campos, MB; de Fátima Santana Ferreira Boin, I; Moura, A; Riguetto, CM, 2022) |
| "Predictive factors for both decreased graft and patient survival included patients recently transplanted (2000-2004), induction without azathioprine, short-term therapy with mycophenolate mofetil and prednisone (< or =6 months), presence of early cholestasis, histologically proven early recurrence of hepatitis C." | 3.74 | Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation. ( Beckebaum, S; Broelsch, CE; Cicinnati, VR; Frilling, A; Gerken, G; Gheorghe, LS; Hilgard, P; Iacob, RA; Iacob, S; Malago, M; Popescu, I, 2007) |
| "We assessed whether conversion from tacrolimus (TAC) to cyclosporine (CsA) was associated with a reduction in hepatitis C virus (HCV) viral load among HCV-positive liver transplant (OLT) patients." | 3.74 | Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study. ( Durand, D; Esposito, L; Faguer, S; Guitard, J; Kamar, N; Lavayssière, L; Lavit, M; Muscari, F; Péron, JM; Ribes, D; Rostaing, L; Sandres-Sauné, K, 2007) |
| "Seven patients with this overlap syndrome (diagnosis based on the presence of serum hepatitis C antibody by RIBA and serum hepatitis C RNA by polymerase chain reaction, and serum hypergammaglobulinemia, elevated ANA or ASMA titers, or histological findings consistent with autoimmune hepatitis) were treated with prednisone with or without azathioprine or cyclosporine, and followed for a median duration of 44." | 3.71 | Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. ( Black, M; Bond, K; Hussain, H; Schiano, TD; Te, HS; Thomas, RM, 2001) |
| "Prophylaxis with norfloxacin has been shown to be effective in preventing spontaneous bacterial peritonitis (SBP) in liver cirrhosis." | 3.71 | Spontaneous bacterial peritonitis caused by quinolone-resistant Escherichia coli: could steroid therapy play a role? ( Cereto, F; del Valle Ortiz, O; Esteban, R; Genescà, J; González, A; Guardia, J; Moreno, G; Smithson, A, 2002) |
| " In this study, this model was applied to investigate the effects of prednisone on alanine aminotransferase (ALT) and hepatitis C virus (HCV) RNA levels in chronic hepatitis C." | 3.69 | Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. ( Adkins, RH; Charboneau, F; Fong, TL; Govindarajan, S; Redeker, AG; Valinluck, B, 1994) |
| "Patients with chronic hepatitis C and autoantibodies show a favorable response to interferon, but not to prednisone." | 3.69 | Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. ( Abreu, L; Albillos, A; Cacho, G; Calleja, JL; Escartín, P; Iborra, J, 1996) |
| "The prednisone dose was reduced from 12." | 2.74 | Cyclosporine A: good response for patients affected by autoimmune disorders and HCV infection? ( Cerquaglia, C; Curigliano, V; De Socio, G; Fonnesu, C; Gasbarrini, G; Giovinale, M; Granata, M; Manna, R; Massafra, U; Migliore, A; Soriano, A; Verrecchia, E, 2009) |
| "Immunosuppression without steroids is safe and reduces infection and metabolic complications." | 2.72 | Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study. ( Baliellas, C; Castellote, J; Fabregat, J; Figueras, J; Garcia-Gil, A; Gonzalez-Pinto, I; Lladó, L; Memba, R; Rafecas, A; Ramos, E; Serrano, T; Torras, J; Xiol, X, 2006) |
| " Future studies should focus on alternative dosing schedules with more aggressive use of adjuvant therapies, including GFs." | 2.71 | Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. ( Ascher, NA; Bollinger, K; Khalili, M; Roberts, JP; Shergill, AK; Straley, S; Terrault, NA, 2005) |
| "Interferon seems to be an effective drug in the treatment of cryoglobulinaemic glomerulonephritis, but dosage and length of treatment still need to be addressed by large multicentre studies." | 2.69 | Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis. ( Baracetti, S; Campanacci, L; Carniello, S; Crovatto, M; Faccini, L; Faelli, A; Mazzaro, C; Mazzi, G; Nascimben, F; Panarello, G; Pozzato, G; Zorat, F, 2000) |
| "Among the rare cases of Sweet syndrome associated to a systemic inflammatory response syndrome that have been described there have not been any fatal cases as occurred with our patient." | 1.34 | [Fatal Sweet syndrome associated to chronic idiopathic systemic inflammatory response syndrome]. ( Almagro, M; del Pozo, J; Fonseca, E; Malmierca, NM; Martín, CG; Martínez, W; Yebra-Pimentel, MT, 2007) |
| "Eleven hemophiliacs with chronic liver disease were studied prospectively for 6 yr, with liver function tests and liver biopsies carried out at intervals of 3 yr." | 1.26 | Nonprogressive course of non-A, non-B chronic hepatitis in multitransfused hemophiliacs. ( Colombo, M; Mannucci, PM; Rizzetto, M, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (8.64) | 18.7374 |
| 1990's | 30 (37.04) | 18.2507 |
| 2000's | 30 (37.04) | 29.6817 |
| 2010's | 11 (13.58) | 24.3611 |
| 2020's | 3 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Campos, MB | 1 |
| Riguetto, CM | 1 |
| de Fátima Santana Ferreira Boin, I | 1 |
| Moura, A | 1 |
| Arcari, A | 1 |
| Tabanelli, V | 1 |
| Merli, F | 1 |
| Marcheselli, L | 1 |
| Merli, M | 1 |
| Balzarotti, M | 1 |
| Zilioli, VR | 1 |
| Fabbri, A | 1 |
| Cavallo, F | 1 |
| Casaluci, GM | 1 |
| Tucci, A | 1 |
| Puccini, B | 1 |
| Pennese, E | 1 |
| Di Rocco, A | 1 |
| Zanni, M | 1 |
| Flenghi, L | 1 |
| Gini, G | 1 |
| Sartori, R | 1 |
| Chiappella, A | 1 |
| Usai, SV | 1 |
| Tani, M | 1 |
| Marino, D | 1 |
| Arcaini, L | 2 |
| Vallisa, D | 1 |
| Spina, M | 2 |
| Umemura, M | 1 |
| Suda, G | 1 |
| Tsukamoto, S | 1 |
| Ebata, K | 1 |
| Takahash, S | 1 |
| Sasaki, T | 1 |
| Nakajima, S | 1 |
| Hirata, K | 1 |
| Ozasa, M | 1 |
| Takano, M | 1 |
| Katagiri, M | 1 |
| Sakamoto, N | 1 |
| Tsutsumi, Y | 1 |
| Nakayama, C | 1 |
| Kamada, K | 1 |
| Kikuchi, R | 1 |
| Kudo, D | 1 |
| Ito, S | 1 |
| Matsuoka, S | 1 |
| Shiratori, S | 1 |
| Yamamoto, Y | 1 |
| Naruse, H | 1 |
| Teshima, T | 1 |
| Rampur, L | 1 |
| Jariwala, S | 1 |
| Amin, B | 1 |
| Patel, P | 1 |
| Rosenstreich, DL | 1 |
| Rosen, D | 1 |
| Chu, J | 1 |
| Morotti, R | 1 |
| Levanon, D | 1 |
| Rose, S | 1 |
| Lee, S | 1 |
| Arnon, R | 1 |
| Zaky, AH | 1 |
| Bakry, R | 1 |
| El-sayed, MI | 1 |
| Elwanis, MA | 1 |
| Nabih, O | 1 |
| Salah-Eldin, MA | 1 |
| Ebrahim, MA | 1 |
| El-Sadda, W | 1 |
| Patel, R | 1 |
| Mikuls, TR | 1 |
| Richards, JS | 1 |
| Kerr, G | 1 |
| Cannon, GW | 1 |
| Baker, JF | 1 |
| Le, V | 1 |
| Bader, T | 1 |
| Fazili, J | 1 |
| Manna, R | 1 |
| Verrecchia, E | 1 |
| Fonnesu, C | 1 |
| Giovinale, M | 1 |
| De Socio, G | 1 |
| Curigliano, V | 1 |
| Cerquaglia, C | 1 |
| Soriano, A | 1 |
| Granata, M | 1 |
| Migliore, A | 1 |
| Massafra, U | 1 |
| Gasbarrini, G | 1 |
| Manzia, TM | 1 |
| Di Paolo, D | 1 |
| Sforza, D | 1 |
| Toti, L | 1 |
| Angelico, R | 1 |
| Brega, A | 1 |
| Angelico, M | 3 |
| Tisone, G | 3 |
| Berenguer, M | 4 |
| Aguilera, V | 2 |
| San Juan, F | 2 |
| Benlloch, S | 2 |
| Rubin, A | 1 |
| López-Andujar, R | 1 |
| Moya, A | 1 |
| Pareja, E | 1 |
| Montalva, E | 1 |
| Yago, M | 1 |
| de Juan, M | 1 |
| Mir, J | 2 |
| Prieto, M | 3 |
| Knyazer, B | 1 |
| Lifshitz, T | 1 |
| Marcus, M | 1 |
| Kratz, A | 1 |
| Zlotnik, A | 1 |
| Levy, J | 1 |
| Nosotti, L | 1 |
| D'Andrea, M | 1 |
| Pitidis, A | 1 |
| Pimpinelli, F | 1 |
| Dessanti, ML | 1 |
| Pisani, F | 3 |
| Vignally, P | 1 |
| Petti, MC | 1 |
| Sagnelli, E | 1 |
| Pisaturo, M | 1 |
| Sagnelli, C | 1 |
| Coppola, N | 1 |
| Brillanti, S | 1 |
| Vivarelli, M | 2 |
| De Ruvo, N | 1 |
| Aden, AA | 1 |
| Camaggi, V | 1 |
| D'Errico, A | 2 |
| Furlini, G | 1 |
| Bellusci, R | 1 |
| Roda, E | 1 |
| Cavallari, A | 1 |
| Frustaci, A | 1 |
| Calabrese, F | 1 |
| Chimenti, C | 1 |
| Pieroni, M | 1 |
| Thiene, G | 1 |
| Maseri, A | 1 |
| Sens, YA | 1 |
| Silva, VD | 1 |
| Malafronte, P | 1 |
| Souza, JF | 1 |
| Miorin, LA | 1 |
| Jabur, P | 1 |
| Miller, EB | 1 |
| Friedman, JA | 1 |
| Huber, MA | 1 |
| Shergill, AK | 1 |
| Khalili, M | 1 |
| Straley, S | 1 |
| Bollinger, K | 1 |
| Roberts, JP | 1 |
| Ascher, NA | 1 |
| Terrault, NA | 1 |
| Kedmi, M | 1 |
| Fridlander, T | 1 |
| Ilan, Y | 1 |
| Shibolet, O | 1 |
| Herman, C | 1 |
| Boggio, L | 1 |
| Green, D | 1 |
| Unholzer, A | 1 |
| Starz, H | 1 |
| Hirschsteiner, O | 1 |
| Balda, BR | 1 |
| Rayón, JM | 2 |
| Berenguer, J | 2 |
| Lladó, L | 1 |
| Xiol, X | 1 |
| Figueras, J | 1 |
| Ramos, E | 1 |
| Memba, R | 1 |
| Serrano, T | 1 |
| Torras, J | 1 |
| Garcia-Gil, A | 1 |
| Gonzalez-Pinto, I | 1 |
| Castellote, J | 1 |
| Baliellas, C | 1 |
| Fabregat, J | 1 |
| Rafecas, A | 1 |
| Couto, M | 1 |
| Conceição, I | 1 |
| de Carvalho, M | 1 |
| Paulli, M | 1 |
| Burcheri, S | 1 |
| Rossi, A | 1 |
| Passamonti, F | 1 |
| Lucioni, M | 1 |
| Motta, T | 1 |
| Canzonieri, V | 1 |
| Montanari, M | 1 |
| Bonoldi, E | 1 |
| Gallamini, A | 1 |
| Uziel, L | 1 |
| Crugnola, M | 1 |
| Ramponi, A | 1 |
| Montanari, F | 1 |
| Pascutto, C | 1 |
| Morra, E | 1 |
| Lazzarino, M | 1 |
| Ammendola, A | 1 |
| Sampaolo, S | 1 |
| Migliaresi, S | 1 |
| Ambrosone, L | 1 |
| Ammendola, E | 1 |
| Ciccone, G | 1 |
| Di Iorio, G | 1 |
| del Pozo, J | 1 |
| Malmierca, NM | 1 |
| Yebra-Pimentel, MT | 1 |
| Almagro, M | 1 |
| Martínez, W | 1 |
| Martín, CG | 1 |
| Fonseca, E | 1 |
| Kedhar, SR | 1 |
| Belair, ML | 1 |
| Jun, AS | 1 |
| Sulkowski, M | 1 |
| Thorne, JE | 1 |
| Fernández, AB | 1 |
| Iacob, S | 1 |
| Cicinnati, VR | 1 |
| Hilgard, P | 1 |
| Iacob, RA | 1 |
| Gheorghe, LS | 1 |
| Popescu, I | 1 |
| Frilling, A | 1 |
| Malago, M | 1 |
| Gerken, G | 1 |
| Broelsch, CE | 1 |
| Beckebaum, S | 1 |
| Burra, P | 1 |
| La Barba, G | 1 |
| Canova, D | 1 |
| Senzolo, M | 1 |
| Cucchetti, A | 1 |
| Guido, M | 1 |
| Merenda, R | 1 |
| Neri, D | 1 |
| Zanello, M | 1 |
| Giannini, FM | 1 |
| Grazi, GL | 1 |
| Cillo, U | 1 |
| Pinna, AD | 1 |
| Guitard, J | 1 |
| Sandres-Sauné, K | 1 |
| Kamar, N | 1 |
| Ribes, D | 1 |
| Faguer, S | 1 |
| Esposito, L | 1 |
| Lavit, M | 1 |
| Muscari, F | 1 |
| Péron, JM | 1 |
| Lavayssière, L | 1 |
| Durand, D | 1 |
| Rostaing, L | 1 |
| Schecter, JM | 1 |
| Mears, JG | 1 |
| Alobeid, B | 1 |
| Gaglio, PJ | 1 |
| Auer, IO | 1 |
| Pastore, G | 1 |
| Tannoia, N | 1 |
| Angarano, G | 1 |
| Monno, L | 1 |
| Santantonio, T | 1 |
| Pietrapertosa, A | 1 |
| Malcangi, G | 1 |
| Putignano, A | 1 |
| Schiraldi, O | 1 |
| Villa, E | 1 |
| Jenkins, P | 1 |
| Portmann, B | 1 |
| Eddleston, AL | 1 |
| Williams, R | 1 |
| Mannucci, PM | 1 |
| Colombo, M | 1 |
| Rizzetto, M | 1 |
| Bellary, S | 1 |
| Schiano, T | 1 |
| Hartman, G | 1 |
| Black, M | 2 |
| Gadano, AC | 1 |
| Mosnier, JF | 1 |
| Durand, F | 1 |
| Martinot-Peignoux, M | 1 |
| Marcellin, P | 1 |
| Degott, C | 1 |
| Belghiti, J | 1 |
| Erlinger, S | 1 |
| Benhamou, JP | 1 |
| Bernuau, JR | 1 |
| Shimizu, Y | 1 |
| Joho, S | 1 |
| Watanabe, A | 1 |
| Fong, TL | 1 |
| Valinluck, B | 1 |
| Govindarajan, S | 1 |
| Charboneau, F | 1 |
| Adkins, RH | 1 |
| Redeker, AG | 1 |
| Magrin, S | 2 |
| Craxi, A | 2 |
| Fabiano, C | 2 |
| Simonetti, RG | 1 |
| Fiorentino, G | 1 |
| Marino, L | 1 |
| Diquattro, O | 1 |
| Di Marco, V | 1 |
| Loiacono, O | 1 |
| Volpes, R | 1 |
| Thiele, DL | 1 |
| DuCharme, L | 1 |
| Cunningham, MR | 1 |
| Mimms, LT | 1 |
| Cuthbert, JA | 1 |
| Lee, WM | 1 |
| Combes, B | 1 |
| Calleja, JL | 1 |
| Albillos, A | 1 |
| Cacho, G | 1 |
| Iborra, J | 1 |
| Abreu, L | 1 |
| Escartín, P | 1 |
| Provenzano, G | 1 |
| Almasio, P | 1 |
| Pinzello, G | 1 |
| Vaccaro, A | 1 |
| Popińska, K | 1 |
| Lyszkowska, M | 1 |
| Ksiazyk, J | 1 |
| Kierkuś, J | 1 |
| Socha, J | 1 |
| Dhôte, R | 1 |
| Calmus, Y | 1 |
| Belenfant, X | 1 |
| Bachmeyer, C | 1 |
| Christoforov, B | 1 |
| Tran, A | 1 |
| Benzaken, S | 1 |
| Yang, G | 1 |
| Schneider, S | 1 |
| Doglio, A | 1 |
| Rampal, A | 1 |
| Rampal, P | 1 |
| Vento, S | 1 |
| Cainelli, F | 1 |
| Concia, E | 1 |
| Ferraro, T | 1 |
| Emilia, G | 1 |
| Luppi, M | 1 |
| Ferrari, MG | 1 |
| Barozzi, P | 1 |
| Marasca, R | 1 |
| Torelli, G | 1 |
| Di Martino, V | 1 |
| Saurini, F | 1 |
| Samuel, D | 1 |
| Gigou, M | 1 |
| Dussaix, E | 1 |
| Reynès, M | 1 |
| Bismuth, H | 1 |
| Féray, C | 1 |
| Möhler, M | 1 |
| Gutzler, F | 1 |
| Kallinowski, B | 1 |
| Goeser, T | 1 |
| Stremmel, W | 1 |
| Córdoba, J | 1 |
| Carrasco, D | 1 |
| Olaso, V | 1 |
| San-Juan, F | 1 |
| Gobernado, M | 1 |
| Pascual, J | 1 |
| Crespo, M | 1 |
| Mateos, ML | 1 |
| Marcén, R | 1 |
| Orofino, L | 1 |
| Burgos, FJ | 1 |
| Liaño, F | 1 |
| Ortuño, J | 1 |
| Ghobrial, RM | 1 |
| Colquhoun, S | 1 |
| Rosen, H | 1 |
| Hollis, P | 1 |
| Ponthieux, S | 1 |
| Pakrasi, A | 1 |
| Farmer, DG | 1 |
| Markman, JF | 1 |
| Markowitz, J | 1 |
| Drazan, K | 1 |
| Yersiz, H | 1 |
| Singer, J | 1 |
| Stribling, R | 1 |
| Arnout, W | 1 |
| Holt, CD | 1 |
| Goss, J | 1 |
| Imagawa, D | 1 |
| Seu, P | 1 |
| Goldstein, LI | 1 |
| Shackleton, CR | 1 |
| Martin, P | 1 |
| Busuttil, RW | 1 |
| Hernández, F | 1 |
| Blanquer, A | 1 |
| Linares, M | 1 |
| López, A | 1 |
| Tarín, F | 1 |
| Cerveró, A | 1 |
| Scelsa, SN | 1 |
| Herskovitz, S | 1 |
| Reichler, B | 1 |
| Rodríguez-Vidigal, FF | 1 |
| Roig Figueroa, V | 1 |
| Pérez-Lucena, E | 1 |
| Ledesma Jurado, V | 1 |
| Ramírez Gurruchaga, P | 1 |
| Aguilar Escobar, FJ | 1 |
| Relea Calatayud, MF | 1 |
| Baz, MJ | 1 |
| Palmieri, G | 1 |
| Anselmo, A | 1 |
| Baiocchi, L | 1 |
| Negrini, S | 1 |
| Orlando, G | 2 |
| Vennarecci, G | 1 |
| Casciani, CU | 2 |
| Magy, N | 1 |
| Cribier, B | 1 |
| Schmitt, C | 1 |
| Ellero, B | 1 |
| Jaeck, D | 1 |
| Boudjema, K | 1 |
| Wolf, P | 1 |
| Labouret, N | 1 |
| Doffoel, M | 1 |
| Kirn, A | 1 |
| Stoll-Keller, F | 1 |
| Marroni, CA | 1 |
| Hoppe, L | 1 |
| Diehl, JL | 1 |
| Leipnitz, I | 1 |
| Brandão, AB | 1 |
| Cassal, AP | 1 |
| Schlindwein, E | 1 |
| Zanotelli, ML | 1 |
| Cantisani, GP | 1 |
| Laria, G | 1 |
| Palmieri, GP | 1 |
| Bellanova, G | 1 |
| Torri, E | 1 |
| Buonomo, O | 1 |
| Koffman, BH | 1 |
| Kennedy, AS | 1 |
| Heyman, M | 1 |
| Colonna, J | 1 |
| Howell, C | 1 |
| Mazzaro, C | 1 |
| Panarello, G | 1 |
| Carniello, S | 1 |
| Faelli, A | 1 |
| Mazzi, G | 1 |
| Crovatto, M | 1 |
| Baracetti, S | 1 |
| Nascimben, F | 1 |
| Zorat, F | 1 |
| Pozzato, G | 1 |
| Faccini, L | 1 |
| Campanacci, L | 1 |
| Marie, I | 1 |
| Levesque, H | 1 |
| Courtois, H | 1 |
| François, A | 1 |
| Riachi, G | 1 |
| Schiano, TD | 1 |
| Te, HS | 1 |
| Thomas, RM | 1 |
| Hussain, H | 1 |
| Bond, K | 1 |
| Cereto, F | 1 |
| Genescà, J | 1 |
| Smithson, A | 1 |
| González, A | 1 |
| Moreno, G | 1 |
| del Valle Ortiz, O | 1 |
| Esteban, R | 1 |
| Guardia, J | 1 |
| Bonnet, F | 1 |
| Morlat, P | 1 |
| Dubuc, J | 1 |
| De Witte, S | 1 |
| Bonarek, M | 1 |
| Bernard, N | 1 |
| Lacoste, D | 1 |
| Beylot, J | 1 |
| Butler, L | 1 |
| Czaja, AJ | 2 |
| Taswell, HF | 2 |
| Rakela, J | 2 |
| Schimek, CM | 2 |
| Jacoby, RF | 1 |
| Brasitus, TA | 1 |
| Rollino, C | 1 |
| Roccatello, D | 1 |
| Giachino, O | 1 |
| Basolo, B | 1 |
| Piccoli, G | 1 |
| Vogten, AJ | 1 |
| Jafri, SM | 1 |
| Mikulecký, M | 1 |
| Hanták, I | 1 |
| Komorník, J | 1 |
| Handlovic, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective Cross-over Study Comparing the Effect of Sirolimus Versus Mycophenolate on Viral Load in Liver Transplant Recipients With Recurrent Chronic HCV Infection[NCT01134952] | Phase 4 | 11 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
| Comparison of Maintenance Treatment by Ribavirin to a Placebo, After an Initial One-year Treatment With Pegylated Interferon-α2a - Ribavirin Association in Hepatitis C Viral Recurrence After Liver Transplantation[NCT00151580] | Phase 3 | 200 participants (Actual) | Interventional | 2002-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | 9 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | 13.8 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | -6.0 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | 1.2 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | -2.7 |
Percent change in HCV load determined 3 months after switch from MMF to SRL. (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | 15 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | -8.5 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | 23 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | 23 |
Percent change in HCV load determined 3 months after switch from SRL to MMF (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | -47 |
(NCT01134952)
Timeframe: 3 month
| Intervention | ng/ml (Mean) |
|---|---|
| MMF SRL Switch | 7.2 |
3 reviews available for prednisone and Hepatitis C
| Article | Year |
|---|---|
Rituximab-based treatment, HCV replication, and hepatic flares.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2012 |
Hepatitis non-A, non-B.
Topics: Animals; Antigen-Antibody Complex; Antigens, Viral; Azathioprine; Hepatitis Antibodies; Hepatitis C; | 1985 |
Treatment of chronic hepatitis B, delta related liver disease and non-A non-B hepatitis.
Topics: Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis, Viral, Human; Humans; Interferons; Prednisone; Vid | 1989 |
11 trials available for prednisone and Hepatitis C
| Article | Year |
|---|---|
Efficacy and prognosis of antiviral therapy on hepatitis C following treatment of lymphoma in HCV-positive diffuse large-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2017 |
Cyclosporine A: good response for patients affected by autoimmune disorders and HCV infection?
Topics: Aged; Autoimmune Diseases; Cyclosporine; Drug Therapy, Combination; Female; Genotype; Hepacivirus; H | 2009 |
Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.
Topics: Adult; Aged; Antiviral Agents; Biopsy; Calcineurin Inhibitors; Chi-Square Distribution; Cyclosporine | 2010 |
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.
Topics: Adult; Aged; Antiviral Agents; Biopsy; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor | 2005 |
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study.
Topics: Adult; Aged; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Diabetes Mellitus; Drug Therapy, Com | 2006 |
Autonomic neuropathy in mixed cryoglobulinemia.
Topics: Action Potentials; Adult; Aged; Autonomic Nervous System Diseases; Cross-Sectional Studies; Cryoglob | 2007 |
Influence of steroids on HCV recurrence after liver transplantation: A prospective study.
Topics: Adult; Aged; Aged, 80 and over; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Middle | 2007 |
Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment.
Topics: Adult; Alanine Transaminase; Carcinoma, Hepatocellular; Chronic Disease; DNA, Viral; Female; Hepaciv | 1994 |
Interferon and steroid treatment in patients with chronic hepatitis C and antinuclear or anti-liver-kidney microsomal antibodies.
Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Autoantibodies; Chronic Disease; Drug Administrat | 1996 |
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation.
Topics: Adult; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Graft Rejection; Graft Survival; | 1999 |
Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis.
Topics: Aged; Anti-Inflammatory Agents; Antiviral Agents; Cryoglobulinemia; Female; Genotype; Glomerulonephr | 2000 |
67 other studies available for prednisone and Hepatitis C
| Article | Year |
|---|---|
Risk factors associated with diabetes after liver transplant.
Topics: Cross-Sectional Studies; Diabetes Mellitus; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantat | 2022 |
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubici | 2023 |
Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case report.
Topics: Aminoisobutyric Acids; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Benzimidazo | 2021 |
DRESS syndrome with suspected Strongyloides infection in a patient treated for hepatitis C.
Topics: Animals; Antiparasitic Agents; Antiviral Agents; Drug Hypersensitivity; Eosinophilia; Hepatitis C; H | 2013 |
Hepatitis C Virus-Autoimmune Hepatitis Overlap Syndrome in an Adolescent.
Topics: Alanine Transaminase; Antibodies, Viral; Aspartate Aminotransferases; Autoantibodies; Azathioprine; | 2015 |
Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2014 |
Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined | 2014 |
Disease characteristics and treatment patterns in veterans with rheumatoid arthritis and concomitant hepatitis C infection.
Topics: Aged; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Comorbidity; Female; Hepatitis | 2015 |
A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone.
Topics: Antiviral Agents; Glucocorticoids; Hearing Loss; Hepatitis C; Humans; Interferon alpha-2; Interferon | 2009 |
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results.
Topics: Azathioprine; Cyclosporine; Graft Survival; Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Immun | 2010 |
Anterior ischemic optic neuropathy in a patient with hepatitis C treated with interferon-alpha and ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Glucocorticoids; Hepatitis C; Humans; Interferon | 2011 |
Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2012 |
Outcome of posttransplantation hepatitis C virus disease--is it the host, the virus, or how we modify the host and/or the virus?
Topics: Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Hepacivirus; Hepatitis C; Humans; Liver | 2002 |
Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation.
Topics: Adult; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; For | 2002 |
Lone hepatitis C virus myocarditis responsive to immunosuppressive therapy.
Topics: Adult; Angiography; Azathioprine; Biopsy, Needle; Cohort Studies; Drug Administration Schedule; Elec | 2002 |
Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus.
Topics: Adult; Brazil; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Hepatitis C; Humans; Immunosuppr | 2004 |
Takayasu's arteritis and hepatitis C: a new association?
Topics: Adult; Antiviral Agents; Azathioprine; Female; Hepacivirus; Hepatitis C; Humans; Interferons; Polyme | 2004 |
Oral lichen planus.
Topics: Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Diagnosis, Differential; Glucocorticoids; | 2004 |
Large solitary splenic diffuse large B cell lymphoma in a hepatitis C virus-infected patient.
Topics: Abdomen; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Biopsy; Cyclophosphamide; Doxor | 2005 |
Factor VIII inhibitor associated with peginterferon.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Drug Therapy, Comb | 2005 |
[Gingival Burkitt lymphoma in a hepatitis C-positive renal transplant patient].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Burkitt Lymphoma; Cyclophosphamide; D | 2005 |
Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
Topics: Adult; Aged; Biopsy; Cohort Studies; Cyclosporine; Disease Progression; Dose-Response Relationship, | 2006 |
Steroid-responsive demyelinating motor neuropathy with conduction block associated with hepatitis C infection and treatment with interferon alpha.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Demyelinating Diseases; Evoked Potentials, Somatosensory | 2006 |
Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxor | 2007 |
[Fatal Sweet syndrome associated to chronic idiopathic systemic inflammatory response syndrome].
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Biopsy; Chronic Disease; Colchicine; Fatal Outcome; Fe | 2007 |
Scleritis and peripheral ulcerative keratitis with hepatitis C virus-related cryoglobulinemia.
Topics: Antiviral Agents; Corneal Ulcer; Cryoglobulinemia; Cyclophosphamide; Drug Therapy, Combination; Eye | 2007 |
An unusual case of autoimmune hemolytic anemia in treatment naïve hepatitis C virus infection.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Female; Hepatitis C; Humans; Leukopenia; Neutropenia; Pancytop | 2006 |
Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation.
Topics: Cohort Studies; Drug Administration Schedule; Female; Graft Rejection; Graft Survival; Hepatitis C; | 2007 |
Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study.
Topics: Aged; Alkaline Phosphatase; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents | 2007 |
Anti-erythropoietin antibody-mediated pure red cell aplasia in a living donor liver transplant recipient treated for hepatitis C virus.
Topics: Anemia; Antibodies; Antiviral Agents; Epoetin Alfa; Erythropoietin; Graft Rejection; Hematinics; Hep | 2007 |
[Therapy of chronic hepatitis (author's transl)].
Topics: Azathioprine; Chronic Disease; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepat | 1980 |
Chronic viral hepatitis in thalassemic liver disease. A long-term study in patients with acute hepatitis with nontransfusion-dependent thalassemia minor.
Topics: Acute Disease; Blood Transfusion; Hepatitis A; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis | 1983 |
Evidence for hepatitis B and other virus infection in HBsAg-negative chronic active hepatitis.
Topics: Adult; Azathioprine; Chronic Disease; Female; Fluorescent Antibody Technique; Hepatitis; Hepatitis B | 1980 |
Nonprogressive course of non-A, non-B chronic hepatitis in multitransfused hemophiliacs.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Child; Chronic Disease; Factor IX; Factor VIII; Foll | 1982 |
Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C: favorable response to prednisone and azathioprine.
Topics: Adult; Aged; Autoimmune Diseases; Azathioprine; Drug Therapy, Combination; Female; Hepatitis C; Hepa | 1995 |
alpha-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimen.
Topics: Azathioprine; Chronic Disease; Cyclosporine; Female; Graft Rejection; Hepatitis C; Humans; Immunosup | 1995 |
Hepatic injury after interferon-alpha therapy for chronic hepatitis C.
Topics: Alprostadil; Chemical and Drug Induced Liver Injury; Chronic Disease; Hepatitis C; Humans; Interfero | 1994 |
Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C.
Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Hepaciv | 1994 |
Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Autoantibodies; Autoimmune Diseases; Base | 1996 |
Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.
Topics: Adult; Alanine Transaminase; Antibodies, Antinuclear; Antiviral Agents; Autoantibodies; Autoimmunity | 1996 |
[Autoimmune enteropathy--difficulties in diagnosis and treatment].
Topics: Autoimmune Diseases; Child, Preschool; Cyclosporine; Diarrhea; Hepatitis C; Humans; Intestinal Disea | 1996 |
[Pneumocystis carinii pneumonia in viral hepatitis C treated with interferon alpha 2 et corticoids].
Topics: Female; Hepatitis C; Humans; Interferon-alpha; Middle Aged; Pneumonia, Pneumocystis; Prednisone | 1996 |
Chronic hepatitis C and autoimmunity: good response to immunosuppressive treatment.
Topics: Aged; Autoantibodies; Autoimmune Diseases; Azathioprine; Chronic Disease; Female; Hepatitis C; Human | 1997 |
Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C.
Topics: Adolescent; Adult; Antiviral Agents; Chronic Disease; Female; Glucocorticoids; Hepatitis C; Hepatiti | 1997 |
Hepatitis C virus-induced leuko-thrombocytopenia and haemolysis.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic | 1997 |
Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation.
Topics: Adult; Disease Progression; Dose-Response Relationship, Drug; Female; Hepacivirus; Hepatitis C; Hepa | 1997 |
Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclophosp | 1997 |
Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection.
Topics: Alanine Transaminase; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Genome, Viral; | 1998 |
Reduced severity of acute rejection in hepatitis C virus positive renal allograft recipients: are milder immunosuppressive regimens advisable?
Topics: Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; | 1998 |
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C; Humans; Immun | 1998 |
Autoimmune thrombocytopenia associated with hepatitis C virus infection.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Autoimmune Diseases; Blood Platelets; Female; Hepati | 1998 |
Treatment of mononeuropathy multiplex in hepatitis C virus and cryoglobulinemia.
Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C; Humans; In | 1998 |
[Alveolar hemorrhage in mixed cryoglobulinemia associated with hepatitis C virus infection].
Topics: Anti-Glomerular Basement Membrane Disease; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; C | 1998 |
Effects of corticosteroids on HCV infection.
Topics: Adrenal Cortex Hormones; Cells, Cultured; Female; Graft Rejection; Hepacivirus; Hepatitis C; Humans; | 1999 |
Diabetes mellitus and liver transplantation in adults.
Topics: Adult; Aged; Azathioprine; Blood Glucose; Brazil; Cyclosporine; Diabetes Mellitus; Hepatitis C; Huma | 1999 |
Effect of steroids amount on hepatitis C recurrence following orthtopic liver transplantation.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; H | 1999 |
Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation.
Topics: Algorithms; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Rejection; Hepatitis C; Human | 2000 |
Polymyositis, cranial neuropathy, autoimmune hepatitis, and hepatitis C.
Topics: Anti-Inflammatory Agents; Cranial Nerve Diseases; Female; Hepatitis C; Hepatitis, Autoimmune; Humans | 2000 |
Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Autoantibodies; Autoimmune Diseases; Drug Therapy | 2001 |
Spontaneous bacterial peritonitis caused by quinolone-resistant Escherichia coli: could steroid therapy play a role?
Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Drug Resistance, Bacterial; Escherichia coli; E | 2002 |
Sarcoidosis-associated hepatitis C virus infection.
Topics: Adult; Aged; Female; Glucocorticoids; Hepatitis C; Humans; Prednisone; Sarcoidosis | 2002 |
Hepatitis: a nurse's story.
Topics: Female; Hepatitis C; Humans; Nursing Staff; Occupational Diseases; Prednisone | 1992 |
Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis.
Topics: Adult; Autoimmune Diseases; Enzyme-Linked Immunosorbent Assay; Female; Hepacivirus; Hepatitis Antibo | 1991 |
Myelodysplastic syndrome and pancytopenia in a patient with non-A, non-B chronic active hepatitis.
Topics: Aged; Hepatitis C; Hepatitis, Chronic; Humans; Male; Myelodysplastic Syndromes; Pancytopenia; Predni | 1991 |
Hepatitis C virus infection and membranous glomerulonephritis.
Topics: Chlorambucil; Female; Glomerulonephritis, Membranous; Hepatitis Antibodies; Hepatitis C; Humans; Mal | 1991 |
Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis.
Topics: Adult; Antibody Specificity; Autoimmune Diseases; Female; Hepacivirus; Hepatitis Antibodies; Hepatit | 1990 |
[Biometric analysis of the effect of prednisone on biochemical indicators in non-A, non-B hepatitis].
Topics: Adolescent; Hepatitis C; Hepatitis, Viral, Human; Humans; Male; Prednisone | 1985 |